Birmingham scientists have identified an essential genetic code for a method called plasmid curing, which aims to "displace" ...

Immune system scientists and computational biologists are developing a new tool to investigate how the body fights disease.

During a live event, Krish Patel, MD, surveyed participants on using bispecific T-cell engagers vs loncastuximab in a patient with relapsed diffuse large B-cell lymphoma who had prior CAR T-cell ...

Burkitt lymphoma, a cancer that impacts a subset of immune cells called B cells, develops most often in children and young adults.  Patients with Burk | Cancer ...

An increasing array of B-cell targeting approaches may aid clinicians in managing the cycles and flares of lupus, according ...

Targeted B cell elimination (INB-619) highlights potential applications in B cell–driven autoimmune diseases as well as cancer ...

Antengene Corporation Limited ('Antengene', SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical ...

This study presents a valuable finding on the direct cytotoxic effects of DuoHexaBody-CD37 in diffuse large B-cell lymphoma, mediated via SHP-1 activation and antibody clustering, independent of ...

CD4 T helper cells are a type of white blood cell called a lymphocyte that serves an important role in your immune system. These cells help defend the body against infection by directing other "killer ...

Chronic lymphocytic leukemia (CLL) cell–derived exosomes demonstrated the ability to alter healthy donor cell function and suppress normal blood cell formation. These particles affected monocytes, ...

However, CD19 absence or loss leads to resistance of the B-lymphoblastic leukemia cells ... the CD19/CD22 CAR-T cells but not CD19 CAR-T cells killed NALM6 cells with loss of CD19 protein but ...